Our leadership team.

Ryan was appointed CEO of Inizio in September 2025, following a four-year tenure as COO, during which he provided strategic leadership across global divisions. In this role, he worked closely with executive management teams to establish and deliver long-term strategic growth plans. Before this, Ryan was COO at UDG Healthcare. He brings over 25 years of experience in the pharmaceutical industry, holding senior commercial leadership roles. Prior to joining UDG Healthcare, Ryan served as Regional Vice President, Region South, and Immunology and HCV Lead for AbbVie Western Europe and Canada. 

Ben was appointed Chief Financial Officer of Inizio following the acquisition of UDG Healthcare, having previously been CFO of Huntsworth Plc. Ben joined Huntsworth Plc in September 2016, stepping up to the Board in 2019. Before joining the team, he worked at ITE Plc, and International Exhibitions Organizer, as Group Financial Controller. Prior to that, Ben worked at Royal Bank of Scotland in banking roles, after training and qualifying with Deloitte in London. In his time at Inizio, Ben has overseen the transformation of the central functions to support the broader integration of the Group and to provide a platform for ongoing growth. 

Colin is Inizio’s Chief Commercial Officer and is responsible for our Commercial Activities and Business Development, with a particular emphasis on the support of our Large Enterprise Accounts and the infrastructure that supports our Global Sales Team. Prior to his current role, he was President of Inizio Advisory from September 2019, where he oversaw Inizio’s Consulting and Research Businesses. Before Inizio, Colin spent 20 years at ICON, where he held several leadership positions, including President of ICON Functional Services. Colin is a seasoned leader in the pharma industry, bringing 30 years of experience across both clinical development and commercialization. He has a strong track record of driving business growth, both organically and through M&A, and improving margins through process optimization. 

Stephanie is the Global Chief People & Culture Officer of Inizio. She joined Inizio in 2022 and leads Inizio's talent strategy and People & Culture team, focusing on transforming the People & Culture organization to deliver a best-in-class experience for our people and differentiate Inizio in the market as a global employer of choice. With over 25 years of international experience as a strategy and management consultant, corporate leader, Chief Human Resources Officer and Board member, Stephanie brings a wealth of cross-industry knowledge and expertise including multi-cultural leadership experience gained working with Fortune 100 clients and leading global teams while living in London, Paris, Prague, Amsterdam and the US. 

Mary-Kate McGarry is Chief Strategy & Innovation Officer at Inizio, where she leads corporate strategy, innovation, global marketing and brand. She joined in 2021 with the Advisory leadership team, driving strategic initiatives following the UDG Healthcare and Huntsworth merger. Mary-Kate spearheaded Inizio’s integrated corporate strategy before assuming her current role, overseeing strategy across the business. She also leads the Group’s commercial innovation agenda - advancing platform development, use-case innovation, investment prioritization and colleague enablement - while shaping global brand positioning to fuel long-term growth. Previously, Mary-Kate spent her career in strategic consulting at EY and Accenture, specializing in large-scale transformation, organizational change, and multi-stakeholder strategy across healthcare, financial services, government, and utilities. 

Gavin McShera is Chief Information Officer at Inizio, where he provides strategic technology leadership across both our corporate functions and global business divisions. In this role, he is responsible for ensuring that technology solutions not only support day-to-day operations but also enable long-term business growth and innovation. Gavin also oversees Inizio’s global cybersecurity strategy - safeguarding critical data, protecting client and employee information, and building a culture of security awareness. He has 30 years of experience across healthcare, finance, professional services, aircraft leasing, retail, public sector, and technology. Before joining Inizio, Gavin was Group CIO at Applegreen PLC, held roles at Microsoft, and worked as an independent consultant. 

Grainne became part of the Inizio team after joining UDG Healthcare in June 2018 as the UDG Head of Finance, with responsibility for Group Finance, Ashfield Finance Functions, Global Procurement & Real Estate, and Finance Transformation. Since joining Inizio, Grainne has led the Finance Transformation projects across the group, partnering with IT to move all businesses to a common financial ERP system, and establishing Shared Services for 30+ Ashfield agencies. Prior to UDG, she worked as General Manager, Ireland, and Vice President, Finance with Alexion, a rare disease US biotech company, leading their expansion in Ireland and a €500 million investment in biologics and packaging facilities in Ireland. Grainne previously spent ten years working with Elan Pharmaceuticals in the United States and Ireland in various corporate, strategic and group finance roles.   

President of Inizio Advisory, Remco leads the Advisory leadership team in facilitating continued growth globally, connecting the organization’s expertise to drive results for clients and create a positive impact on patients. Remco joined Putnam, a strategy consulting firm and part of Inizio Advisory, in 2000, spending the first 12 years as a strategic advisor to several top 20 biopharma companies. After becoming a Partner in 2012, Remco supported the growth of the firm from a small boutique to one of the leading global life science strategy consultancies. In 2019, Remco became the CEO of Putnam and supported the team in driving strong organic growth and managing strategically relevant acquisitions to make the firm what it is today – a strong 400+ team and leading advisory organization for the life sciences. 

Joining Medistrava in 2015, Elaine helped double the size of the organization through organic growth and acquisition to create a fully integrated medical, health economics and market access platform. Now, she joins us as President of Inizio Medical. As a trained neuropsychologist, Elaine has enjoyed a career in research and clinical practice before joining the industry, combining her background in science and behavior to drive evidence-based strategies that apply to real-world healthcare challenges.

Reid Connolly leads Inizio Evoke, a global health marketing, communications, and transformation platform dedicated to making health more human™. Since founding Evoke in 2006, Reid has been instrumental in evolving the agency into one of the most progressive, client-centric, and people-first agencies in the industry, embracing its digital and data-driven roots to create a uniquely integrated platform. Reid has also been recognized by PRWeek as one of the industry’s top voices, with honors on both the Health Influencer 50 and Health Influencer 30 lists. Prior to founding Evoke, Reid held senior leadership roles at Digitas Health, imc2, and Saatchi & Saatchi Healthcare, where he honed his expertise in integrated healthcare marketing. He has partnered with leading pharmaceutical and biotech companies, including AstraZeneca, Amgen, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Novartis, and Pfizer.

Jim is the president of Inizio Engage, and an accomplished senior commercial leader with over 25 years’ experience in healthcare launching, building and/or growing blockbuster products, and successfully leading complex and dynamic businesses. Jim is a senior pharma executive who has consistently led teams to deliver strong financial results, he is also the Founder and President of Sage Advice Consulting. His last pharma role was as the North American Regional President for Pfizer’s Internal Medicine’s business and US Country Manager. He has also held general management positions as a Regional President for Pfizer’s Hospital and Generics businesses, and as the Country Manager for Greece. He has an extensive marketing background, including having served as VP of Primary Care Marketing for Pfizer in the US and Europe. Jim has helped to build some of Pfizer biggest and most successful brands, including Lipitor and Eliquis. 

Paul is the Founding CEO of Inizio, where he shaped the company’s vision and led its growth for four transformative years before stepping into his current role as Advisor. Prior to this, Paul was appointed as CEO of Huntsworth plc in April 2015. He turned Huntsworth into a leading healthcare advisory business before taking the company private under CD&R. Before this, Paul enjoyed a 20-year career in London and New York with Hill & Knowlton Inc., the global communications consultancy and subsidiary of WPP plc, including nine years as its Chairman and CEO. During this time, Paul advised numerous blue-chip and international clients across all geographies and sectors. 

Neil is an experienced Executive Director. He was the former CFO & COO of Huntsworth prior to the merger with UDG which formed Inizio. Before joining Huntsworth, Neil was CFO for several UK-listed public companies, having originally qualified as an accountant with PWC in the early 90’s. Before transitioning to an Advisor, Neil served as Corporate Development Director at Inizio where he was the head of M&A, leading on the Nucleus and Research Partnership transactions. He also lead property focusing on delivering the optimal property solution (space and environments) for employees, and served as the executive sponsor for both Sustainability and Inclusion & Impact - helping to shape strategy and deliver a best-in-class positioning for the company. He is also the Chairman of Accordience, Inizio’s non-healthcare PR agency Group. 

Liam is the former CEO of UDG Healthcare. He led the company from 2000 to 2016. Under his leadership he grew the business into a multi-faceted and multi-national healthcare services group with operations across 20 countries. During his tenure he integrated more than 30 acquisitions into the parent company. Liam is an operating advisor to CD&R funds, a private investment firm, headquartered in New York and London.     Liam has a B.Comm. from the University College Dublin and an M.Sc., business studies, from the Michael Smurfit Graduate Business School. 

Eric is a partner at private investment firm, CD&R. He joined the firm in 2005. Eric leads the European team’s healthcare vertical and has been deeply involved in many of those investments including in UDG, and its subsequent separation to form Inizio and Sharp. Prior to CD&R Eric worked in the investment banking division of J.P. Morgan and as a management consultant. Eric graduated from ESSEC Graduate School of Management and ENSAM Graduate School of Engineering, Paris.

Dave is Co-President of private investment firm, CD&R where he is a member of the Investment and Executive committees. Dave leads the firm’s European business, overseeing all its investment verticals including healthcare investments. He is also responsible for the firm’s external relations activities. Prior to CD&R, Dave worked in the private equity and investment banking divisions of Morgan Stanley. Dave is a member of the Amherst College Board of Trustees and the Cambridge University Endowment Fund Investment Advisory Board. He is an Advisor to Ahren Innovation Capital. He has an M.B.A. from Harvard Business School and a B.A. from Amherst College.

Sarah is a partner at private investment firm, CD&R. She joined CD&R in 2008 and is a member of the Firm’s Inclusion Committee. Based in New York, Sarah is deeply involved in the Firm’s healthcare focused investments, including Inizio. Previously, she held positions at private equity firms Metalmark Capital and McCown De Leeuw & Co. and worked in the investment banking division of Goldman Sachs & Co. Ms. Kim also serves on the board of the Healthcare Private Equity Association. Sarah has a J.D. from Harvard Law School, an M.B.A. from Harvard Business School, and a B.A. in economics and political science from Yale University.

Sid is a partner at private investment firm, CD&R, where he is principally engaged in evaluating investment opportunities in the healthcare sector. He played a key role in the firm’s investment in Inizio. Prior to joining CD&R, Sid was responsible for private equity investments in the healthcare sector at EQT Partners and Advent International. Sid has a B.A. (Hons) in accounting, finance, and business information systems from the University of Manchester.

Stephen is a member of the Inizio Board. Stephen Cameron founded Nucleus Global (part of Inizio Medical) in 1986, leading it to become the largest independent medical communications networks in the world. He served as Chairman and CEO overseeing the company's growth and its acquisition by Huntsworth in 2020. Stephen has a BSc from University of Sussex in Materials Science,  an MSc in Bio-medical Engineering from University of Strathclyde, Glasgow, a DPhil in Bio-medical Engineering from the University of Sussex, and a postgraduate degree in Marketing from the Polytechnic of Central London.

Ryan was appointed CEO of Inizio in September 2025, following a four-year tenure as COO, during which he provided strategic leadership across global divisions. In this role, he worked closely with executive management teams to establish and deliver long-term strategic growth plans. Before this, Ryan was COO at UDG Healthcare. He brings over 25 years of experience in the pharmaceutical industry, holding senior commercial leadership roles. Prior to joining UDG Healthcare, Ryan served as Regional Vice President, Region South, and Immunology and HCV Lead for AbbVie Western Europe and Canada. 

Ben was appointed Chief Financial Officer of Inizio following the acquisition of UDG Healthcare, having previously been CFO of Huntsworth Plc. Ben joined Huntsworth Plc in September 2016, stepping up to the Board in 2019. Before joining the team, he worked at ITE Plc, and International Exhibitions Organizer, as Group Financial Controller. Prior to that, Ben worked at Royal Bank of Scotland in banking roles, after training and qualifying with Deloitte in London. In his time at Inizio, Ben has overseen the transformation of the central functions to support the broader integration of the Group and to provide a platform for ongoing growth. 

Paul is the Founding CEO of Inizio, where he shaped the company’s vision and led its growth for four transformative years before stepping into his current role as Advisor. Prior to this, Paul was appointed as CEO of Huntsworth plc in April 2015. He turned Huntsworth into a leading healthcare advisory business before taking the company private under CD&R. Before this, Paul enjoyed a 20-year career in London and New York with Hill & Knowlton Inc., the global communications consultancy and subsidiary of WPP plc, including nine years as its Chairman and CEO. During this time, Paul advised numerous blue-chip and international clients across all geographies and sectors.